The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Black Stone Minerals Common 09225M101 35,120 5,719,924 SH   SOLE   5,719,924 0 0
Unity Biotechnology Inc Common 91381U101 5,439 1,571,981 SH   SOLE   1,571,981 0 0
Evelo Bioseciences Inc Common 299734103 2,556 484,953 SH   SOLE   484,953 0 0
Biosig Tech Inc Common 09073N201 4,974 100,891 SH   SOLE   100,891 0 0
Clearpoint Neuro Inc (fka MRI INTERVENTIONS INC) Common 18507C103 2,574 47,148 SH   SOLE   47,148 0 0
CANCER GENETICS INC Common 13739U203 184 444 SH   SOLE   444 0 0
SPDR ETF Common 78462F103 5,529 16,511 SH   SOLE   16,511 0 0
Zentalis Pharmaceuticals Inc Common 98943L107 14,472 442,714 SH   SOLE   442,714 0 0
Exact Sciences Corp Common 30063P105 3,353 3,289 SH   SOLE   3,289 0 0